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Abstract
Objective Vestibular evoked myogenic potentials (VEMPs) have been suggested as biomarkers in the differential diagnosis 
of Menière’s disease (MD) and vestibular migraine (VM). The aim of this study was to compare the degree of asymmetry 
for ocular (o) and cervical (c) VEMPs in large cohorts of patients with MD and VM and to follow up the responses.
Study design Retrospective study in an interdisciplinary tertiary center for vertigo and balance disorders.
Methods cVEMPs to air-conducted sound and oVEMPs to bone-conducted vibration were recorded in 100 patients with 
VM and unilateral MD, respectively. Outcome parameters were asymmetry ratios (ARs) of oVEMP n10p15 and cVEMP 
p13n23 amplitudes, and of the respective latencies (mean ± SD).
Results The AR of cVEMP p13n23 amplitudes was significantly higher for MD (0.43 ± 0.34) than for VM (0.26 ± 0.24; 
adjusted p = 0.0002). MD—but not VM—patients displayed a higher AR for cVEMP than for oVEMP amplitudes (MD 
0.43 ± 0.34 versus 0.23 ± 0.22, p < 0.0001; VM 0.26 ± 0.14 versus 0.19 ± 0.15, p = 0.11). Monitoring of VEMPs in single 
patients indicated stable or fluctuating amplitude ARs in VM, while ARs in MD appeared to increase or remain stable over 
time. No differences were observed for latency ARs between MD and VM.
Conclusions These results are in line with (1) a more common saccular than utricular dysfunction in MD and (2) a more 
permanent loss of otolith function in MD versus VM. The different patterns of o- and cVEMP responses, in particular their 
longitudinal assessment, might add to the differential diagnosis between MD and VM.
Keywords Vestibular evoked myogenic potentials · Menière’s disease · Saccule · Utricle · Vestibular migraine
Introduction
Vestibular evoked myogenic potentials (VEMPs) are short-
latency, mainly otolith-driven vestibular reflexes elicited 
by air-conducted sound (ACS), bone-conducted vibration 
(BCV), or galvanic vestibular stimulation and recorded 
from the inferior oblique eye muscle (ocular or oVEMPs) 
or the sternocleidomastoid muscle (cervical or cVEMPs). 
While the oVEMP n10 response predominantly represents 
contralateral dynamic utricular function, the cVEMP p13n23 
amplitude is predominantly an indicator of ipsilateral sac-
cular function [1, 2]. Today, VEMPs are widely used as a 
diagnostic marker for superior canal dehiscence in clinical 
practice [3]. Their role in the differential diagnosis between 
Menière’s disease (MD) and vestibular migraine (VM) war-
rants, however, further research [4].
The current diagnostic criteria for MD and VM developed 
by the Classification Committee of the Bárány Society are 
mainly based on patients’ history and symptoms. Depending 
on the number of fulfilled inclusion criteria, the diagnosis is 
categorized as “definite” (d) or “probable” (p). In short, MD 
is defined by at least two recurrent vertigo attacks lasting 
20 min to 12 h, audiometrically documented low- to middle-
frequency sensorineural hearing loss related to the vertigo 
attacks, and fluctuating aural symptoms (e.g., tinnitus, aural 
fullness) in the affected ear [5]. The pathogenesis of MD has 
been linked to endolymphatic hydrops (ELH) of the inner 
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ear, which appears to be a necessary, but not sufficient condi-
tion for the development of MD [6, 7].
On the other hand, the diagnostic criteria for VM include 
at least five vertigo attacks between 5 min and 72 h, accom-
panied by at least one migraine symptom (i.e., visual aura, 
migraine-type headache, photo-/phonophobia) in at least 
50% of the attacks and/or a positive history of migraine [8]. 
The pathophysiology of vestibular migraine is not entirely 
clear to date. In summary, a combination of central (e.g., a 
reciprocal connection between the trigeminal and vestibular 
nuclei, abnormal neurotransmitter modulation in the brain-
stem) and peripheral pathophysiology (e.g., neurogenic 
inflammation of the inner ear mediated by projections of 
the trigeminovascular system to the labyrinthine artery) 
most likely explains the various clinical presentations of 
this multi-facetted disorder [9, 10].
Despite the progress in classification of vestibular disor-
ders, the differential diagnosis between MD and VM in clini-
cal practice is often difficult due to the episodic and fluctu-
ating nature of both diseases and the considerable overlap 
of symptoms and, eventually, diseases [11, 12]. Therefore, 
biomarkers to distinguish between the two disorders would 
be highly valuable. As a first step, it is important to identify 
possible markers that differ between patients and healthy 
subjects. A number of studies have compared VEMPs from 
patients with either MD (e.g., [15, 16]) or VM (e.g., [20, 
21]) to healthy controls, indicating their diagnostic utility for 
both disorders. As a second step, the biomarker should aid 
the differential diagnosis between MD and VM in patients 
whose history and symptoms cannot be clearly attributed to 
one of the disorders [12]. Studies comparing the different 
patterns of o- and cVEMP responses between patients with 
MD and VM are, however, scarce.
Concerning absolute amplitudes, Baier and Dieterich 
[23] reported no difference for ACS cVEMPs in VM ver-
sus MD; Zuniga et al. [24] observed reduced amplitudes 
for ACS oVEMPs in unilateral MD as compared to VM. 
Studies comparing VEMP asymmetry ratios (ARs) include 
Inoue et al. [25], who described higher ACS oVEMP ARs 
in unilateral MD (77%) versus VM (57%), but equal asym-
metry ratios for BCV oVEMPs (27% versus 34%) and ACS 
cVEMPs (51% versus 44%). On the other hand, Taylor et al. 
[26] and Salviz et al. [27] reported a significantly higher 
AR for ACS cVEMP amplitudes in patients with unilateral 
MD (46% and 29%) as compared to those with VM (16% 
in both studies). Despite some inconsistent results, the AR 
studies generally indicated that VEMP amplitudes of MD 
patients were more asymmetric than those in VM. None 
of these studies, however, included more than 60 patients 
with each disorder or performed VEMP recordings at dif-
ferent time points. Furthermore, the diagnostic criteria of 
the Bárány Society for MD and VM were not applied in 
all of the studies; in particular, none of them distinguished 
between possible and definite MD.
Therefore, the primary aim of the present study was to 
test whether c- and oVEMPs displayed different degrees 
of asymmetry in a large cohort of consecutive, unselected 
patients with MD or VM according to the Bárány Society 
classification criteria. Second, we investigated whether these 
results allow “definite” and “probable” disease categories 
of MD and VM to be distinguished from each other. Third, 
we analyzed in some cases whether the episodic character 
of VM and MD is reflected by fluctuating VEMP responses 
obtained at different points in time.
Materials and methods
Study subjects
For this retrospective study, the medical records of consecu-
tive patients with VM or MD, who had received VEMP test-
ing at the German Center of Vertigo and Balance Disorders 
or the Department of Neurology at the University Hospital 
of the Ludwig-Maximilians-Universität, Munich, Germany, 
in 2012–2013 and 2017–2019, were screened. One hundred 
(100) patients were included in the MD and the VM group, 
respectively. The MD group comprised 85 patients with defi-
nite MD (dMD) and 15 patients with probable MD (pMD), 
while the VM group consisted of 35 patients with definite 
VM (dVM) and 65 patients with probable VM (pVM). In 
addition to those patients, four MD and five VM patients, 
who had received serial VEMP measurements over time, 
were identified and analyzed separately.
All subjects underwent a thorough neurotological 
workup, i.e., history-taking, clinical examination, and 
additional vestibular diagnostics, including caloric irriga-
tion of the horizontal canals, video head impulse testing 
for the semicircular canal function in the high-frequency 
range, examination of the subjective visual vertical and fun-
dus photography with a scanning laser ophthalmoscope for 
static graviceptive function. In addition, c- and oVEMPs, 
posturography, gait analysis, and pure tone audiometry were 
performed if necessary.
Patients were included in the study if they had received 
VEMP testing and fulfilled the diagnostic criteria of 
the Bárány Society for either vestibular migraine [8] or 
Menière’s disease [5]. All patient records were reviewed by 
a neurotology specialist for the presence of the diagnostic 
criteria defining the definite and probable forms of the dis-
orders before inclusion in the study. Patients were excluded 
from the study if they had reported overlapping symptoms 
of MD and VM or if they fulfilled the diagnostic criteria for 
both disorders based on their history.
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Moreover, the following groups of patients were excluded: 
bilateral MD, MD with a history of migraine, patients with 
further vestibular or neurological disorders (e.g., benign 
paroxysmal positional vertigo, vestibular paroxysmia, inner 
and outer labyrinthine fistula, vestibular neuritis, vestibu-
lar schwannoma, cerebellar ataxia, extrapyramidal motor 
disorders, dementia, multiple sclerosis, stroke), middle ear 
disease (e.g., cholesteatoma, otosclerosis, chronic otitis 
media, tympanic effusion), or an air–bone gap in pure tone 
audiometry on the day of the VEMP recording. Furthermore, 
patients with a history of ear surgery (including but not lim-
ited to tympanoplasty, stapes surgery, endolymphatic sac 
surgery, intratympanic gentamicin, and labyrinthectomy), 
brain surgery, or concussion were excluded.
VEMP recordings
VEMPs were recorded as described previously [1] with one 
of the three VEMP platforms routinely used in the German 
Center for Vertigo and Balance Disorders and the Depart-
ment of Neurology, i.e., the Nicolet on Viking EDX evoked 
potential system (Natus, Pleasanton, CA, USA), the Eclipse 
platform (Interacoustics, Middelfart, Denmark), or the Neu-
ropack M1 platform (Nihon Kohden, Tokyo, Japan). Only 
those VEMP responses that were clearly discernible from 
background noise were included in the analysis. To avoid 
bias due to different recording platforms and examiners, only 
asymmetry ratios of VEMP amplitudes and latencies were 
analyzed in detail (see “Outcome parameters”).
oVEMPs
For oVEMPs, the surface recording electrode was placed on 
the infraorbital rim, the reference electrode 1–2 cm below, 
and the ground electrode was fixed around the wrist. Patients 
lay supine and looked up during the recording to increase the 
oVEMP n10 amplitude [2]. A BCV stimulus was delivered 
to the midline of the forehead at the hairline (Fz) by a pow-
erful bone-conduction device (minishaker 4810, Bruel and 
Kjaer, Naerum, Denmark) connected to an amplifier (type 
2718, Bruel and Kjaer, Naerum, Denmark). A custom-made 
Matlab program (MathWorks, Natick, MA, USA) was used 
to produce 500 Hz tone burst BCV stimuli (rise/fall time: 
0 ms, plateau: 2 ms, driving voltage: 5 V, stimulus repeti-
tion rate: 3 pulses per second (pps)). Responses below the 
right and left eyes were recorded simultaneously; the analy-
sis window was 20 ms from stimulus onset. The EMG sig-
nal was amplified and bandpass filtered (10 Hz – 1.5 kHz). 
Twenty unrectified traces were averaged per recording, and 
at least two trials were run in one subject to ensure reliability 
and reproducibility of the VEMP signal. Amplitudes and 
latencies from reproducible recordings were averaged for the 
right and left ear, respectively (see “Outcome parameters”).
cVEMPs
For cVEMPs, the recording electrode was placed over the 
mid third of the sternocleidomastoid muscle (SCM), and 
the reference electrode over the sternoclavicular junction. 
The ground electrode was fixed around the wrist. During 
the recording, the subject lifted the head in the midline 
from a semi-recumbent position to maintain sufficient 
symmetric muscular activity in the SCM of either side 
for recording the inhibitory cVEMP response [2]. 500 Hz 
ACS tone burst stimuli (130 dB peak sound pressure level, 
rise/fall time: 1 ms, plateau: 5 ms, 3 pps) were applied 
consecutively to either ear by TDH-39P headphones 
(Telephonics, Framingdale, NY, USA). The recording 
window was 50 ms from stimulus onset. The EMG sig-
nal was amplified and bandpass filtered (10 Hz – 2 kHz), 
and 50 unrectified traces were averaged per recording. As 
described for oVEMPs above, amplitudes and latencies 
were calculated as average from at least two reproducible 
recordings.
Outcome parameters
For oVEMPs, amplitudes and latencies of the first negative 
(n10) and the first positive (p15) peak were determined 
as a measure of contralateral (mainly) utricular function, 
while the first positive (p13) and the first negative peak 
(n23) of the cVEMP response were used as parameters for 
ipsilateral (mainly) saccular function [2].
To rule out any systematic differences between the three 
different sets of recording equipment and different examin-
ers, we did not compare absolute amplitudes and latencies 
between subjects, but only ARs between the right and left 
sides within each subject. Amplitude ARs were calculated 
as described before [28]:
AR values range between 0 (symmetric response on 
both sides) and 1 (absent response on one side). Asymme-
try ratios were determined for oVEMP n10p15 amplitudes 
and cVEMP p13n23 amplitudes. ARs > 0.3 (oVEMPs) and 
ARs > 0.4 (cVEMPs) were considered to indicate asym-
metry between the two sides, respectively, based on the 
normative values of our laboratory as well as data from 
the literature [2, 28].
Latency ARs were calculated accordingly for n10 
and p15 latencies (oVEMPs) and p13 and n23 latencies 
AR = | right amplitude − left amplitude | ∕
| right amplitude + left amplitude |.
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(cVEMPs) in addition to n10p15 and p13n23 inter-peak 
intervals. All values are presented in mean ± standard 
deviation (SD).
Data analysis
Data were entered into an Excel 2013 spreadsheet (Micro-
soft, Redmond, WA, USA) and analyzed with GraphPad 
Prism 8.3.1 software (GraphPad, San Diego, CA, USA). 
For all statistical tests, an (adjusted) p value < 0.05 was 
considered to indicate a statistically significant difference. 
Age between the MD and VM groups was compared using 
the two-sided unpaired Student’s t test, gender distribution 
between the two groups was analyzed with the two-sided 
Fisher’s exact test. Simple linear regression was employed 
to determine a possible correlation between VEMP ARs 
and age, and a p value < 0.05 was considered to indicate a 
slope significantly different from zero. For the comparison 
of amplitude ARs between different groups, we used the 
Brown-Forsythe and Welch ANOVA test, as SDs were sig-
nificantly different for the individual groups. ANOVA was 
followed by Dunnett’s T3 test to correct for multiple com-
parisons. Finally, latency ARs between the MD and the VM 




Individuals with MD were signif icantly older 
(58 .85  ± 13 .85   years )  t han  those  wi th  VM 
(36.03 ± 19.49 years) (two-sided unpaired t test: p < 0.0001; 
Table 1). The female proportion was significantly lower in 
MD (38%) as compared to VM (70%) (two-sided Fisher’s 
exact test: p < 0.0001).
Asymmetry ratio of VEMP amplitudes
Asymmetry ratios of oVEMP n10p15 and cVEMP p13n23 
peak-to-peak amplitudes (oVEMP and cVEMP amplitude 
ARs) are shown in Fig. 1.
First, ARs between MD and VM were compared. No sig-
nificant statistical difference was observed for the oVEMP 
amplitude AR (Fig. 1a) between the MD (0.23 ± 0.22) and 
the VM group (0.19 ± 0.15) (ANOVA with multiple com-
parisons: adjusted p value = 0.35). In addition, the oVEMP 
Table 1  Subjects’ demographic information
MD  Menière’s disease, VM  vestibular migraine
MD (n = 100) VM (n = 100) p value
Age (years; 
mean ± SD)




38: 62 (0.6: 1) 70: 30 (2.3: 1) p < 0.0001 (two-sided 
Fisher’s exact test)
Fig. 1  Asymmetry ratio (AR) for ocular and cervical vestibular 
evoked myogenic potentials (o- and cVEMPs) in Menière’s disease 
(MD) and vestibular migraine (VM) (mean + standard deviation 
(SD), ns not significant, ***adjusted p value < 0.001). a Compari-
son of oVEMP ARs between MD and VM, probable versus definite 
MD (pMD/dMD) and probable versus definite VM (pVM/dVM). 
No difference was observed between the groups. b Comparison of 
cVEMP ARs between MD and VM, probable versus definite MD 
(pMD/dMD) and probable versus definite  VM (pVM/dVM). cVEMP 
amplitude AR was significantly higher in MD than in VM (adjusted p 
value = 0.0002). c Comparison of o- versus cVEMP amplitude ARs in 
MD and VM. cVEMP amplitude AR was higher than oVEMP ampli-
tude AR for MD (adjusted p value < 0.0001), but not for VM patients
Journal of Neurology 
1 3
amplitude AR did not discriminate between those subjects 
with probable versus definite MD (pMD 0.15 ± 0.14, dMD 
0.25 ± 0.23; adjusted p = 0.09) and probable versus definite 
VM (pVM 0.17 ± 0.14, dVM 0.23 ± 0.16; adjusted p = 0.93). 
Neither the MD nor the VM group showed a correlation 
between age and oVEMP amplitude ARs (simple linear 
regression; MD: p = 0.93; VM: p = 0.67).
On the other hand, cVEMP amplitude AR (Fig. 1b) was 
significantly higher for subjects with MD (0.43 ± 0.34) as 
compared to those with VM (0.26 ± 0.24) (ANOVA with 
multiple comparisons: adjusted p value = 0.0002). As 
observed for oVEMPs, cVEMP amplitude ARs did not differ 
between probable and definite MD (pMD 0.49 ± 0.36, dMD 
0.41 ± 0.34; adjusted p = 0.81) and between probable and 
definite VM subgroups (pVM 0.24 ± 0.22; dVM 0.30 ± 0.27; 
adjusted p = 0.60). No correlation between cVEMP ampli-
tude AR and age was observed for both disorders (simple 
linear regression; MD p = 0.51; VM p = 0.39).
Second, we determined the degree of asymmetry for o- 
versus cVEMPs within one group of patients (MD or VM, 
Fig. 1c). For MD, the amplitude AR was significantly higher 
for c- than for oVEMPs (0.43 ± 0.34 versus 0.23 ± 0.22; 
adjusted p value < 0.0001), while there was no difference 
between c- and oVEMP ARs for patients with VM (cVEMPs 
0.26 ± 0.14; oVEMPs 0.19 ± 0.15; adjusted p value = 0.11).
Third, cVEMP ARs in MD were further analyzed with 
respect to the affected ear. Only three patients displayed an 
increased p13n23 amplitude on the affected side. All of them 
had experienced audio-vestibular symptoms typical of MD 
for less than 2 years. On the other hand, those MD patients 
with reduced cVEMP amplitudes on the affected side had a 
mean disease duration of 8.6 years.
In summary, (1) the mean cVEMP amplitude AR was 
higher for MD than for VM patients, (2) patients with MD 
had a significantly higher mean amplitude AR for cVEMPs 
than for oVEMPs, and (3) increased cVEMP amplitudes on 
the affected side were only observed in early stages of MD.
Asymmetry ratio of VEMP latencies
Asymmetry ratios were calculated for peak latencies 
(oVEMP n10 and p15; cVEMP p13 and n23) and inter-peak 
intervals (oVEMP n10p15; cVEMP p13n23) and are sum-
marized in Table 2. No statistically significant difference 
was observed for all peak latencies and inter-peak intervals 
Table 2  Asymmetry ratios (ARs) of peak and inter-peak latencies 
for ocular and cervical vestibular evoked myogenic potentials in sub-
jects with Menière’s disease (MD) and vestibular migraine (VM), 
mean ± SD
An adjusted p value < 0.05 in the two-sided unpaired t test corrected 
for multiple comparisons was considered to indicate a significant dif-
ference between groups
MD (n = 100) VM (n = 100) Adjusted p value
AR n10 peak 
latency
0.03 ± 0.03 0.03 ± 0.04  > 0.99
AR p15 peak 
latency
0.03 ± 0.02 0.03 ± 0.02  > 0.99
AR n10p15 interval 0.09 ± 0.08 0.08 ± 0.07 0.72
AR p13 latency 0.05 ± 0.05 0.04 ± 0.04 0.47
AR n23 latency 0.04 ± 0.04 0.03 ± 0.03 0.25
AR p13n23 interval 0.11 ± 0.14 0.09 ± 0.07 0.60
Fig. 2  Serial measurements of the asymmetry ratio for ocular ves-
tibular evoked myogenic potentials (AR oVEMPs, grey squares) and 
cervical vestibular evoked myogenic potentials (AR cVEMPs, black 
circles) in two patients with vestibular migraine (VM 1 and VM 
2) showing either fluctuating or stable degrees of asymmetry. See 
Table 3 for a summary of the patients’ clinical data
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between the MD and the VM groups (two-sided unpaired 
t test corrected for multiple comparisons; all adjusted p 
values > 0.05).
Monitoring of VEMPs in single patients
For five VM and four MD patients, multiple VEMP record-
ings from follow-up visits were available. Due to the small 
number of patients and the inter-individual differences 
in disease duration/activity and follow-up intervals, no 
statistical analysis was performed. Figures 2 and 3 show the 
development of o- and cVEMP amplitude ARs over time 
in those patients in whom data from at least three different 
points in time were available. The basic clinical information 
(e.g., symptoms, number of attacks, results of vestibular test-
ing) of these patients is summarized in Table 3.  
Patient VM 1 (Fig. 2a) had a 7-year history of pVM at the 
beginning of the monitoring (January 2014) and displayed 
a fluctuating level of oVEMP ARs (0.38–0.70), while the 
cVEMP AR was relatively low and stable (< 0.2) over the 
next 18 months. Patient VM 2 (Fig. 2b), on the other hand, 
had suffered from dVM for only 1 year at the time of the first 
cVEMP measurement in June 2016. Here, highly variable 
cVEMP amplitude ARs ranging between 0.13 and 0.70 were 
observed between June 2016 and January 2017.
Two patients with dMD (MD 1 and MD 2) were followed 
over 3 years each. For both patients, o- and cVEMP ampli-
tudes recorded from the affected labyrinth were smaller than 
or equal to those from the contralateral side. Patient MD 1, 
who presented with a 1-year history of left-sided MD in 
April 2016, showed a slow increase in cVEMP amplitude 
AR (0.01–0.28) followed by a plateau, while the oVEMP 
AR remained < 0.1 for 3 years (Fig. 3a). Patient MD 2 had 
experienced MD vertigo attacks with accompanying audi-
tory symptoms and Tumarkin drop attacks for 8 years when 
he had his first examination in October 2015. His cVEMP 
amplitude AR was stable around 0.6 with a slight increase 
over time, while the oVEMP amplitude AR increased 
between 2015 and 2018 from 0.08 to 0.37 (Fig. 3b).
Discussion
The present study compared c- and oVEMP responses in 
large cohorts of 100 patients with MD and VM, respec-
tively, from an interdisciplinary tertiary center for vertigo 
and balance disorders. The most important findings were 
(1) the asymmetric cVEMP response pattern for MD ver-
sus VM, (2) the higher degree of cVEMP as compared to 
oVEMP amplitude asymmetry for MD, and (3) variable 
degrees in asymmetry for VEMP responses in both MD 
and VM patients over time.
VEMP responses in Menière’s disease
The higher cVEMP amplitude AR for unilateral MD 
patients versus VM patients in the present study (Fig. 1b) 
confirms the findings by Taylor et  al. [26] and Salviz 
et al. [27] in smaller patient groups and emphasizes a piv-
otal role of the saccule in the pathogenesis of MD. The 
high AR may either result from increased ACS cVEMP 
Fig. 3  Serial measurements of the asymmetry ratio for ocular ves-
tibular evoked myogenic potentials (AR oVEMPs, grey squares) and 
cervical vestibular evoked myogenic potentials (AR cVEMPs, black 
circles) in two patients with Menière’s disease (MD 1 and MD 2) 
showing either increasing or stable ARs. See Table 3 for a summary 
of the patients’ clinical data
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amplitudes on the affected side in early stages of the dis-
ease, which have been attributed to the distended sac-
cular membrane contacting the stapes footplate, or from 
reduced amplitudes on the affected side in later stages of 
the disease [16, 29, 30], probably due to a progressive 
loss of vestibular hair cells and primary vestibular neurons 
[33, 34]. In line with this, the three MD patients with an 
increased cVEMP amplitude on the affected side in our 
study had experienced audio-vestibular symptoms for less 
than 2 years, whereas those with a reduced amplitude had 
a mean disease duration of 8.6 years. Histopathological 
analyses in MD have shown that the saccule is affected 
more often by ELH than the utricle [35]. This finding is 
reflected by the higher degree of asymmetry for cVEMP 
as compared to oVEMP amplitudes in the MD patients of 
our study (Fig. 1c).
The discrepancy in the ARs of c- and oVEMPs for MD 
observed in the present study is also noteworthy with respect 
to inner ear neurophysiology, as it implies that ACS cVEMPs 
and BCV oVEMPs originate in two different subsets of ves-
tibular hair cells, namely those of the saccule and the utricle 
[36]. Furthermore, the different asymmetry ratios for o- and 
cVEMPs in MD indicate that the endolymphatic volumes 
in the utricle and in the saccule are regulated independently 
from each other. The utriculo-endolymphatic valve (Bast’s 
valve) at the junction between the utricle and utricular duct 
seems to play an important role in this process [37]. Studies 
in guinea pigs have shown that saccular hydrops compresses 
the utricular duct and closes Bast’s valve, thus allowing nor-
mal endolymphatic pressure to be maintained in the utricle 
independent of endolymphatic volume and pressure in the 
saccule [16, 38].
The low degree of asymmetry for BCV oVEMP ampli-
tudes of MD patients in the present study (Fig. 1a) confirms 
the results from Inoue et al. [25]. On the other hand, a higher 
AR for ACS oVEMP amplitudes was observed for MD than 
VM in the latter study. One probable reason for this discrep-
ancy might be the fact that BCV is generally a more power-
ful stimulus than ACS. Therefore, mild utricular damage 
might not be detected by BCV, whereas it might be sufficient 
to cancel the small ACS-induced response [24, 25].
Amplitude ARs in the present study did not allow dis-
crimination between probable and definite forms of MD 
(Fig.  1a, b). For oVEMP amplitude ARs, there was a 
tendency towards a higher degree of asymmetry in dMD 
than pMD, which would be in line with a more common 
involvement of the utricle in advanced stages of the disease. 
The results did, however, not reach the level of statistical 
significance in multiple comparisons, which might be due 
to the low number of patients in the pMD group (n = 15). 
Therefore, a larger number of patients with pMD should be 
examined in future studies to further analyze a possible pro-
gression of utricular damage from probable to definite MD.
VEMP responses in vestibular migraine
In general, the low and similar degrees of asymmetry for 
o- and cVEMP amplitudes in VM (Fig. 1c) indicate a com-
mon central pathology affecting the utricle and the saccule 
of both labyrinths equally. Possible mechanisms include the 
reciprocal connection between the trigeminal and vestibular 
nuclei and an abnormal neurotransmitter modulation in the 
vestibular nuclei. Furthermore, the trigeminovascular system 
projects to the labyrinthine arteries of either labyrinth, which 
might result in symmetrical involvement of both labyrinth 
organs in VM [9]. The symmetrical responses for o- and 
cVEMPs in VM fit with the recent observation of mild bilat-
eral ELH in inner ear magnetic resonance imaging (MRI) of 
patients with VM [39].
In this context, it is important to note that the degree 
of the mild bilateral ELH fluctuated over time in the latter 
case report. In line with this finding, we detected fluctuat-
ing degrees of asymmetry for o- and cVEMP amplitudes 
in serial examinations of VM patients in the present study 
(Fig. 2). In particular, the high degrees of ARs up to 0.7 
point to a temporary asymmetry between right- and left-
sided otolith function, which might be due to temporary uni-
lateral hypoperfusion of the labyrinthine artery [10] or an 
asymmetric ELH. In summary, the VEMP response pattern 
of VM patients in the present study strengthens the notion 
that this disorder is caused by a combination of fluctuating 
(and not persisting) peripheral and central pathologies [20].
As observed for MD above, VEMP amplitude ARs were 
not able to discriminate between probable and definite cases 
of the disease (Fig. 1a, b). This is in line with the notion that 
VM is an episodic disorder that does not result in permanent 
damage of the vestibular organs in the inner ear.
Regarding the ARs for o- and cVEMP latencies, there 
was no difference between MD and VM in the present study 
(Table 2). Although this finding does not allow any conclu-
sions about absolute latencies, it indicates that the central 
pathology in VM does most likely not involve unilateral 
demyelination in the brainstem, which has been linked to 
prolonged VEMP latencies [21].
Diagnostic utility of VEMPs in distinguishing 
Menière’s disease from vestibular migraine
The paramount aim of the present study was to determine 
whether different patterns of o- and cVEMP responses in 
MD and VM might be helpful for the differential diagno-
sis between the two disorders. Of all the parameters ana-
lyzed, only the cVEMP amplitude AR yielded a statistically 
significant difference between the two groups (Fig. 1b: 
mean = 0.43 ± 0.34 for MD and 0.26 ± 0.24 for VM). This 
parameter is, however, only of limited value in clinical 
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practice due to the broad range and the overlap of results for 
the two disorders in this study.
It has been recommended to combine the inter-aural 
cVEMP amplitude AR for 500 Hz ACS with the 500–1000-
Hz frequency tuning ratio of either ear to increase the diag-
nostic accuracy of VEMPs in differentiating MD patients 
from healthy subjects and VM patients [19, 26]. Monitoring 
of VEMP responses over time might be another promising 
approach to achieve this aim.
Monitoring of VEMPs in single patients
In this retrospective study, VEMP responses from at least 
three different points in time were only available for two VM 
and two MD patients (Figs. 2, 3), as VEMP monitoring was 
not routinely performed in our vertigo clinic in each patient. 
Although the informative value of these data is very limited 
at the moment, a systematic analysis of VEMP responses 
over time in MD and VM patients, particularly those with 
overlapping symptoms, might be useful in future clinical 
studies.
The most important finding in this study was the variabil-
ity in VEMP amplitude ARs over time for both disorders. It 
should be particularly noted that o- and cVEMP ARs change 
independently within one patient (e.g. Fig. 3a) adding fur-
ther evidence to the notion that o- and cVEMPs originate in 
two different subsets of vestibular receptors, i.e., the utricle 
and the saccule [36].
The longitudinal development of VEMP responses 
was studied in MD patients in more detail during the last 
20  years. Fluctuating o- and cVEMP amplitudes were 
recorded in the early stages of MD disease, particularly 
shortly before and after an attack [29, 36], while patients 
with long-standing disease typically displayed decreasing 
VEMP amplitudes on the affected side and thus increas-
ing ARs, reflecting a progressive permanent damage to the 
sensory epithelia of the labyrinth [16, 32]. In line with this, 
patient MD 1 with a 1-year history displayed an increase 
in cVEMP amplitude ARs within the next 3 years due to 
decreasing amplitudes on the affected side (Fig. 3a). The 
lower AR values for o- versus cVEMPs in this patient reflect 
the mean results for the whole MD group and fit with a 
predominance of saccular rather than utricular dysfunction. 
Patient MD 2, on the other hand, had experienced both MD 
vertigo and Tumarkin attacks for 8 years (Fig. 3b). Tumar-
kin attacks, which occur in about 5% of MD patients, are 
considered to arise from abrupt changes of endolymphatic 
pressure in the otolith organs. Based on histopathological 
and VEMP studies, Tumarkin attacks are thought to be trig-
gered by residual utricular function, while structural damage 
and absent cVEMPs indicated severe saccular dysfunction 
[16]. In accordance with results from a previous study [40], 
the relatively stable cVEMP amplitude AR of 0.6 (Fig. 3b) 
was due to reduced amplitudes on the affected (left) side, 
indicating chronic saccular dysfunction on the left, while 
the slightly increasing oVEMP amplitude AR fits with 
residual, but deteriorating left-sided utricular dysfunction. 
Furthermore, patient MD 2 had a normal caloric response 
(horizontal semicircular canal function) on the affected side 
(Table 3), as observed before in 40% of patients with Tumar-
kin attacks [40].
The issue of temporal changes in VEMP responses has, 
however, received less attention in VM so far. To the best 
of our knowledge, only one study has compared cVEMP 
recordings between patients with MD and VM at two differ-
ent points in time. Van Tilburg and coworkers [41] observed 
an increase in cVEMP amplitude AR after a mean follow-
up period of 2 years in MD patients, while no significant 
changes were observed in VM patients. Although the results 
of the present study are very preliminary due to the small 
sample size, they indicate variable degrees of asymmetry 
over time (in particular in patient VM 2 with a short disease 
history), in contrast to the steady increase in AR observed 
for the two MD patients (Figs. 2, 3). This aspect warrants 
further research. Fluctuating peripheral and central vestibu-
lar dysfunctions in VM were also reflected by the variable 
degrees of inter-ictal ocular motor abnormalities in patient 
VM 1 and the caloric asymmetry in patient VM 2 (Table 3). 
Such findings are quite commonly observed in VM [11].
Strengths and limitations of the present study
Patient demographics
Overall, patients with VM were younger than those with 
MD in the present study, reflecting the earlier mean age of 
disease onset for patients with VM as compared to MD [12]. 
It is very unlikely that the higher AR for cVEMP amplitudes 
in MD is due to the older age of these patients, as ARs do 
not correlate with age in the present study, for either the MD 
or the VM group.
Moreover, the female proportion was higher in VM as 
compared to MD in our patients, which is in line with a 
recent meta-analysis on this topic [42]. Thus, the present 
study comprises representative samples of MD and VM in 
terms of age and gender.
Strengths
To the best of our knowledge, this is the first study com-
paring o- and cVEMPs between patients with MD and VM 
using the Bárány Society classifications for both disorders, 
whereas previous studies applied the Neuhauser [43] or 
Bárány Society criteria [8] for VM and the criteria of the 
American Academy for Otolaryngology-Head and Neck Sur-
gery (AAO-HNS) for MD [44]. In contrast to other studies, 
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which only differentiated between probable and definite VM 
(e.g., [23, 26]), we included a separate analysis of VEMPs 
in patients with pMD and dMD. Thus, this study helps to 
implement the Bárány Society’s International Classification 
of Vestibular Disorders in clinical research, which will hope-
fully facilitate the comparison between different studies in 
the future.
Moreover, this is the largest study published so far 
comparing VEMPs in patients with MD and VM (n = 100 
patients each). Finally, we provide a first insight into the 
longitudinal development of VEMP amplitude ARs in VM, 
an aspect that has been neglected so far.
Limitations
There are, however, several limitations to the present study. 
First, this is a retrospective study from a tertiary neurotol-
ogy center, which might result in a selection bias towards 
patients with more severe forms of MD and VM. In addition, 
disease duration/activity, treatment and follow-up intervals 
differed between patients and groups. A further limitation 
is the fact that we had to rely on patients’ history from the 
medical records to differentiate between MD and VM, and 
between probable and definite forms of the disorders. This 
information may be incomplete and subject to recall bias.
Second, our aim of reflecting everyday clinical practice 
in a large vertigo clinic means that patients were examined 
by different examiners and with different measurement set-
ups. To minimize the risk of systematic differences between 
examiners and sets of equipment, we did not compare abso-
lute VEMP amplitudes and latencies between patients, but 
only asymmetry ratios comparing amplitudes and latencies 
within one subject. Furthermore, only those serial measure-
ments from one patient that had been recorded with the same 
setup were included in the study, which limited the number 
of follow-up measurements available for analysis.
Outlook
The observation of fluctuating VEMP responses in VM 
should be analyzed systematically over several years in 
further studies. In particular, the correlation of VEMP 
amplitudes/AR with clinical symptoms and inner ear ELH 
deserves special attention. For MD, both the degree of ELH 
in the affected ear [45, 46] and the AR of cVEMP ampli-
tudes increase over time [32, 41], which is in line with pro-
gressive permanent damage to the sensory epithelia of the 
labyrinth. Assuming that VM does not result in permanent 
hair cell damage or neuronal degeneration of the inner ear, 
we hypothesize that VEMP amplitudes/AR and the degree of 
ELH would fluctuate over time without progressive deterio-
ration as observed for MD. Thus, the different longitudinal 
development of VEMP responses might aid the differential 
diagnosis of the two disorders.
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